| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―05 |
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary |
Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa |
| 2 |
[GO] |
2024―Mar―26 |
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies |
Abundio Balgos, Suad AI Hannawi, Wen-Li Chen, Alaa Abuquta, Linda Safeldin, Aala Hassan, Ahmad Alamadi, Louie Tirador, Anjuli May Jaen, Ralph Elvi Villalobos, Chen Mo, Zi-Jing Yue, Ying Ma, Qing-Shuang Wang, Ren-Du Wen, Zheng Yao, Jia-Ping Yu, Wen-Rong Yao, Jian-Hui Zhang, Kun-Xue Hong, Yong Liu, Jing-Xin Li |
| 3 |
[GO] |
2024―Mar―22 |
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 omicron variant |
Gabiria Pastore, Jacopo Polvere, Fabio Fiorino, Simone Lucchesi, Giorgio Montesi, Ilaria Rancan, Sara Zirpoli, Arianna Lippi, Miriam Durante, Massimiliano Fabbiani, Mario Tumbarello, Francesca Montagnani, Donata Medaglini, Annalisa Ciabattini |
| 4 |
[GO] |
2024―Feb―27 |
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan |
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto |
| 5 |
[GO] |
2024―Feb―20 |
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis |
Alberto San Francisco Ramos, Carolina Liu Sanchez, Tatiana Bovill Rose, David Smith, Natasha Thorn, Eva Galiza, Thahmena Miah, Jennifer Pearce, Cecilia Hultin, Catherine Cosgrove, Yingfen Hsia, Paul T. Heath |
| 6 |
[GO] |
2024―Feb―19 |
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine |
Viravarn Luvira, Punnee Pitisuttithum |
| 7 |
[GO] |
2024―Jan―30 |
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS) |
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Shingo Masuda, Ryosuke Osawa, Naoto Hosokawa, Kei Nakashima, Hiroshi Kamura, Haruki Imura, Hiroki Inoue, Suguru Matsuzaka, Yukihiro Sugimoto, Osamu Kuwamitsu, Iori Motohashi, Toru Morikawa, Rentaro Oda, Yuiko Hoshina, Takashi Matono, Osamu Teshigahara, Eiichiro Sando, Sadaharu Asami, Satoshi Kudo, Noboru Akizuki, Yoshikazu Muto, Tomoichiro Hayakawa, Tomoo Kishaba, Yasuji Ohara, Yoshinao Kubo, Motoi Suzuki, Konosuke Morimoto |
| 8 |
[GO] |
2023―Dec―08 |
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data |
Yiming Li, Sori K Lundin, Jianfu Li, Wei Tao, Yifang Dang, Yong Chen, Cui Tao |
| 9 |
[GO] |
2023―Dec―04 |
Modelling the potential public health impact of different COVID-19 vaccination strategies with an adapted vaccine in Singapore |
Ben Yarnoff, Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Bulent Taysi, Josie Dodd, Helen M Oh |
| 10 |
[GO] |
2023―Nov―27 |
A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson’s disease |
Hui Han, Dan Zhao, Xinru Fang, Wenming Yang, Mengli Wang, Qianzhuo Liu, Luyao Wang, Zhihui Ji, Juan Zhang, Zhifeng Hou, Lei Hua, Yu Wang, Limin Wu |
| 11 |
[GO] |
2023―Oct―25 |
Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older |
Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, Yuting Liao, Lingfeng Yuan, Gang Chen, Huakun Lv |
| 12 |
[GO] |
2023―Oct―25 |
Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination |
Ruyun Gao, Cuiling Zheng, Mengwei Yang, Liyuan Dai, Chen Chen, Jiarui Yao, Zhishang Zhang, Le Tang, Yuankai Shi, Xiaohong Han |
| 13 |
[GO] |
2023―Oct―19 |
Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study |
Yajie Gong, Xi Zhang, Xue Han, Baolan Chen, Yingxia Xu, Jitian Huang, Wenhan Yang, Xi Fu, Qiancui Wang, Zhongjun Li, Chunfeng Wu, Tianran Shen, Yuting Fan, Yingshi Dai, Yaping Qiao, Gang Zeng, Jikai Zhang, Qingsong Chen |
| 14 |
[GO] |
2023―Oct―16 |
No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation |
Ting Du, Qiuxia Qu, Yawen Zhang, Qin Huang |
| 15 |
[GO] |
2023―Oct―16 |
Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America |
Maria L. Avila Agüero, Jose Brea Del Castillo, Luiza Helena Falleiros-Arlant, Eitan Berezín, Jose Cassio de Moraes, Carlos Torres-Martínez, Eduardo L. Lopez, María E. Castillo, Almudena Laris-Gonzalez, Fortino Solorzano, Angela Gentile, Juan Pablo Torres Torretti, Eduardo López-Medina |
| 16 |
[GO] |
2023―Sep―19 |
Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine |
Angel Shabu, Prasad S Nishtala |
| 17 |
[GO] |
2023―Aug―22 |
Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: a systematic review and meta-analysis |
Silvio Tafuri, Francesco Paolo Bianchi, Eustachio Cuscianna, Donato Rizzi, Noemi Signorile, Antonio Daleno, Giovanni Migliore |
| 18 |
[GO] |
2023―Jul―28 |
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov |
Shen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, Jing-Xin Li, Feng-Cai Zhu |
| 19 |
[GO] |
2023―Jul―11 |
Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial |
Yan-Fei Wu, Ming-Wei Wei, Rui-Jie Wang, Xi-Ling Guo, Hong-Xing Pan, Ya-Chun Gao, Xiao-Long Li, Xue Wang, Xiao-Min Ma, Peng Wan, Li Zhou, Ya-Wen Zhu, Jing-Xin Li, Feng-Cai Zhu |
| 20 |
[GO] |
2023―Jul―07 |
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era |
Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa |
| 21 |
[GO] |
2023―Jul―07 |
Risk of herpes zoster following mRNA COVID-19 vaccine administration |
Ana Florea, Jun Wu, Lei Qian, Bruno Lewin, Lina S. Sy, I-Chun Lin, Jennifer H. Ku, Hung Fu Tseng |
| 22 |
[GO] |
2023―Jun―30 |
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines |
Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, Yong Poovorawan |
| 23 |
[GO] |
2023―Jun―08 |
Understanding COVID-19 vaccination decisions during pregnancy and while breastfeeding in a Canadian province |
Kate Lee, Monica Surti, Marcia Bruce, Greis Beharaj, Gerald F. Giesbrecht, Eliana Castillo |
| 24 |
[GO] |
2023―May―30 |
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access |
Peter J. Hotez, Rakesh Adhikari, Wen-Hsiang Chen, Yi-Lin Chen, Portia Gillespie, Nelufa Y. Islam, Brian Keegan, Rakhi Tyagi Kundu, Jungsoon Lee, Zhuyun Liu, Jason T. Kimata, Numan Oezguen, Jeroen Pollet, Cristina Poveda, Kay Razavi, Shannon E. Ronca, Ulrich Strych, Syamala R. Thimmiraju, Leroy Versteeg, Maria Jose Villar-Mondragon, Junfei Wei, Bin Zhan, Maria Elena Bottazzi |
| 25 |
[GO] |
2023―May―23 |
Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study |
Amanda L. Eiden, Anthony DiFranzo, Alexandra Bhatti, H. Echo Wang, Goran Bencina, Lixia Yao, Kunal Saxena, Ya-Ting Chen, Stephanie A. Kujawski |
| 26 |
[GO] |
2023―May―10 |
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines |
Xiaoqing Guan, Yang Yang, Lanying Du |
| 27 |
[GO] |
2023―May―03 |
Safety outcomes associated with the Moderna COVID-19 vaccine (mRNA-1273): a literature review |
Angel Shabu, Prasad S. Nishtala |
| 28 |
[GO] |
2023―May―03 |
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses |
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks |
| 29 |
[GO] |
2023―Apr―20 |
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses |
Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray |
| 30 |
[GO] |
2023―Apr―05 |
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks? |
Basant E. Katamesh, Maysa Madany, Fatma Labieb, Abdelaziz Abdelaal |
| 31 |
[GO] |
2023―Mar―15 |
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews |
Thuan Tong Tan, Heng Joo Ng, Barnaby Young, Behram Ali Khan, Vikram Shetty, Nura Azmi, Steve Clissold |
| 32 |
[GO] |
2023―Mar―10 |
Shoulder injury following COVID-19 vaccine administration: a case series and proposed diagnostic algorithm |
Nikki Petrakis, Mel Addison, Bianca Penak, Silja Schrader, John Mallard, Hazel J Clothier, Jim P. Buttery, Nigel W. Crawford, Daryl R Cheng |
| 33 |
[GO] |
2023―Mar―08 |
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS) |
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Takayasu Ito, Hideko Ikeda, Hiroshi Kamura, Iori Motohashi, Yuya Kimura, Masaru Komino, Hiromi Arai, Osamu Kuwamitsu, Nobuhiro Akuzawa, Eiichiro Sando, Toru Morikawa, Haruki Imura, Hiroki Inoue, Tomoichiro Hayakawa, Osamu Teshigahara, Yasuji Ohara, Motoi Suzuki, Konosuke Morimoto |
| 34 |
[GO] |
2023―Feb―23 |
Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness |
Paula Mc Kenna, Lindsay A. Broadfield, Annik Willems, Serge Masyn, Theresa Pattery, Ruxandra Draghia-Akli |
| 35 |
[GO] |
2023―Feb―20 |
Can protein vaccines for COVID-19 win over the vaccine-hesitant? |
E. Adrianne Hammershaimb, Milagritos D. Tapia |
| 36 |
[GO] |
2023―Feb―20 |
COVID-19 vaccines: the start of a new era in regulation? |
Peter W. Marks |
| 37 |
[GO] |
2023―Jan―30 |
Understanding the mechanisms for COVID-19 vaccine’s protection against infection and severe disease |
Huijie Yang, Ying Xie, Changgui Li |
| 38 |
[GO] |
2023―Jan―23 |
“Vaccinate my village” strategy in Malawi: an effort to boost COVID-19 vaccination |
Sanjay Singhal, Ghanshyam Sethy, Mike Nenani Chisema, Lokesh Sharma, Krupal Joshi, Patrick Omar Nicks, Beverly Laher, Kondwani Chidzammbuyo Mamba, Kunal Deokar, Tedla Damte, John Phuka |
| 39 |
[GO] |
2022―Dec―17 |
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data |
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, Moe H. Kyaw, John M. McLaughlin, Jennifer L. Nguyen |
| 40 |
[GO] |
2022―Dec―15 |
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance |
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L. Nguyen, Libby Hamson, Manuela Di Fusco, Carole Czudek, Jingyan Yang |
| 41 |
[GO] |
2022―Dec―09 |
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review |
Cristian Sandoval, Daniela Guerrero, Joham Muñoz, Karina Godoy, Vanessa Souza-Mello, Jorge Farías |
| 42 |
[GO] |
2022―Nov―22 |
Cardiovascular safety of COVID-19 studies: vaccines in real-world a systematic review and meta-analysis |
Yafei Chang, Guoli Lv, Chao Liu, Erwen Huang, Bin Luo |
| 43 |
[GO] |
2022―Nov―17 |
Success of nano-vaccines against COVID-19: A transformation in nanomedicine |
Manoj Kumar Sarangi, Sasmita Padhi, Gautam Rath, Sitansu Sekhar Nanda, Dong Kee Yi |
| 44 |
[GO] |
2022―Nov―04 |
Expert Review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic |
Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, Do Dung, Kao-Pin Hwang, Javier Ortiz Ibarra, Sasisopin Kiertiburanakul, Prasad S. Kulkarni, Christopher Lee, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Lisa Ong-Lim, Alfonso J. Rodriguez-Morales, Rosana Richtmann, Marco Aurélio Palazzi Safadi, Hindra Irawan Satari, Guy Thwaites |
| 45 |
[GO] |
2022―Oct―15 |
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis |
Angela Meggiolaro, Monica Sane Schepisi, Sara Farina, Carolina Castagna, Alessia Mammone, Andrea Siddu, Paola Stefanelli, Stefania Boccia, Giovanni Rezza |
| 46 |
[GO] |
2022―Sep―05 |
Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs |
Oluyemisi Falope, Mawuli K. Nyaku, Ciara O’Rourke, Lindsay V. Hermany, Brittany Plavchak, Josephine Mauskopf, Louise Hartley, Margaret E. Kruk |
| 47 |
[GO] |
2022―Sep―01 |
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above |
Zhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, Peng-Fei Jin, Shi-Hua Ma, Hong-Xing Pan, Jin-Long Zhang, Yong-Mei Shan, Hai-Tao Huang, Shi-Po Wu, Pan Du, Xue Wang, Li-Li Wang, Rui-Jie Wang, Ying Wang, Xue-Wen Wang, Feng-Cai Zhu, Jing-Xin Li |
| 48 |
[GO] |
2022―Aug―30 |
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? |
Kyu-Bin Oh, T. Mark Doherty, Volker Vetter, Paolo Bonanni |
| 49 |
[GO] |
2022―Aug―25 |
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza |
Ekaterina Stepanova, Irina Isakova-Sivak, Larisa Rudenko |
| 50 |
[GO] |
2022―Aug―22 |
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2 |
Igor Age Kos, Maximilian Kiefer, Katharina Brill, Onur Cetin, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Sigrun Smola, Stefan Lohse, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Frank Neumann, Moritz Bewarder, Lorenz Thurner |
| 51 |
[GO] |
2022―Aug―20 |
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks |
Abdolreza Esmaeilzadeh, Armin Jahani Maleki, Amirhosein Moradi, Amir Siahmansouri, Mohammad Javad Yavari, Parsa Karami, Reza Elahi |
| 52 |
[GO] |
2022―Aug―18 |
COVID-19 and vaccination: myths vs science |
Vivek P. Chavda, Yangmin Chen, Jayant Dave, Zhe-Sheng Chen, Subhash C. Chauhan, Murali M. Yallapu, Vladimir N. Uversky, Rajashri Bezbaruah, Sandip Patel, Vasso Apostolopoulos |
| 53 |
[GO] |
2022―Aug―15 |
Further implications on the global real-world vaccine effectiveness against SARS-CoV-2 |
Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, Do Van Dung, Kao-Pin Hwang, Sasisopin Kiertiburanakul, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Ong-Lim, Javier Ortiz Ibarra, Rosana Richtmann, Alfonso J. Rodriguez-Morales, Marco Aurélio P Safadi, Hindra Irawan Satari |
| 54 |
[GO] |
2022―Aug―11 |
COVID-19 vaccine design and vaccination strategy for emerging variants |
Vivek P Chavda, Vasso Apostolopoulos |
| 55 |
[GO] |
2022―Aug―05 |
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management |
Vivek P Chavda, Aayushi B. Patel, Lalitkumar K Vora, Vasso Apostolopoulos, Bruce D. Uhal |
| 56 |
[GO] |
2022―Aug―04 |
Vaccines against SARS-CoV-2 variants and future pandemics |
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, Sang Gu Kang, Seunghyup Song, Young Hun Kim, Hanbi Kim, Eun-Ju Ko, Soon-Do Yoon, Sang-Moo Kang, Hye Suk Hwang |
| 57 |
[GO] |
2022―Jul―25 |
Personal and contextual determinants of COVID-19 vaccination intention: a vignette study |
Sofie Morbée, Joachim Waterschoot, Vincent Yzerbyt, Olivier Klein, Olivier Luminet, Mathias Schmitz, Omer Van den Bergh, Pascaline Van Oost, Silke De Craene, Maarten Vansteenkiste |
| 58 |
[GO] |
2022―Jul―21 |
Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China |
Li-na Yan, Zhong-xin Zhao, Zhen-dong Wang, Xiao Xiao, Pan-pan Liu, Wen-kang Zhang, Xiao-lan Gu, Bang Li, Li-ping Yu, Xue-jie Yu |
| 59 |
[GO] |
2022―Jul―20 |
COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021 |
Christopher J Floyd, Grace E Joachim, Matthew L Boulton, Jon Zelner, Abram L Wagner |
| 60 |
[GO] |
2022―Jul―13 |
The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and meta-analysis |
Hamid Reza Baradaran, Hojat Dehghanbanadaki, Farhad Moradpour, Babak Eshrati, Ghobad Moradi, Mobin Azami, Abdolkarim Hajighadery, Mohammad-Mehdi Mehrabinejad, Yousef Moradi |
| 61 |
[GO] |
2022―Jul―12 |
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis |
Francesco Paolo Bianchi, Pasquale Stefanizzi, Maria Cristina Di Gioia, Nazario Brescia, Sabrina Lattanzio, Silvio Tafuri |
| 62 |
[GO] |
2022―Jul―11 |
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States |
Sophia Hatziantoniou, Cleo Anastassopoulou, George Lazaros, Konstantinos Vasileiou, Costas Tsioufis, Athanasios Tsakris |
| 63 |
[GO] |
2022―Jul―07 |
Comparing Reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis |
Natalina Sutton, Alberto San Francisco Ramos, Emily Beales, David Smith, Sabina Ikram, Eva Galiza, Yingfen Hsia, Paul T. Heath |
| 64 |
[GO] |
2022―Jul―06 |
Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine |
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda |
| 65 |
[GO] |
2022―Jun―28 |
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study |
Toshio Naito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Morikuni Tobita, Satoshi Hori, Suminobu Ito |
| 66 |
[GO] |
2022―Jun―27 |
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis |
Francesco Paolo Bianchi, Pasquale Stefanizzi, Nazario Brescia, Sabrina Lattanzio, Andrea Martinelli, Silvio Tafuri |
| 67 |
[GO] |
2022―Jun―24 |
Expert Review on global real-world vaccine effectiveness against SARS-CoV-2 |
Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Dung Do-Van, Masliyana Husin, Kao-Pin Hwang, Sasisopin Kiertiburanakul, Prasad S. Kulkarni, Ping-Ing Lee, Rommel Crisenio Lobo, Cao Huu Nghia, Anna Ong-Lim, Sheamini Sivasampu, Jing Lian Suah, Peter Seah Keng Tok, Guy Thwaites |
| 68 |
[GO] |
2022―Jun―13 |
Making COVID-19 mRNA vaccines accessible: challenges resolved |
Sarfaraz K. Niazi |
| 69 |
[GO] |
2022―Jun―13 |
SARS-CoV-2 the ASIA virus (autoimmune/autoinflammatory syndrome induced by adjuvants), the risk of infertility and vaccine hesitancy |
Rohan Ameratunga |
| 70 |
[GO] |
2022―Jun―02 |
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines |
Jessica A. Neil, Maryanne Griffith, Dale I. Godfrey, Damian F. J. Purcell, Georgia Deliyannis, David Jackson, Steve Rockman, Kanta Subbarao, Terry Nolan |
| 71 |
[GO] |
2022―May―23 |
The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19? |
Amresh Kumar, Amit Ladha, Ankita Choudhury, Abu Md Ashif Ikbal, Bedanta Bhattacharjee, Tanmay Das, Gaurav Gupta, Chhavi Sharma, Adity Sarbajna, Subhash C Mandal, Manabendra Dutta Choudhury, Nahid Ali, Petr Slama, Nima Rezaei, Partha Palit, Onkar Nath Tiwari |
| 72 |
[GO] |
2022―May―20 |
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo? |
Jonny Jonny, Terawan Agus Putranto, Enda Cindylosa Sitepu, Raoulian Irfon |
| 73 |
[GO] |
2022―May―19 |
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study |
Valeria Fano, Enzo Coviello, Dario Consonni, Alessandro Agresta, Nicola Orsini, Alessia Crielesi, Antonio Salvatore Miglietta, Caterina Pasqua, Francesco Vairo, Fabio Vivaldi, Giuseppe De Angelis, Giovanni Colaiocco, Massimo Fabiani |
| 74 |
[GO] |
2022―May―13 |
Safety profile of COVID-19 vaccines, preventive strategies and patient management |
M. Mukhyaprana Prabhu, Subish Palaian, Mukhtar Ansari |
| 75 |
[GO] |
2022―May―11 |
Responding to new challenges: is there a need to relook and revise our COVID-19 vaccination strategy? |
Vipin M. Vashishtha, Puneet Kumar |
| 76 |
[GO] |
2022―May―06 |
Reply to: Correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination” |
Michele Gringeri, Vera Battini, Gianluca Cammarata, Giulia Mosini, Greta Guarnieri, Chiara Leoni, Marco Pozzi, Sonia Radice, Emilio Clementi, Carla Carnovale |
| 77 |
[GO] |
2022―Apr―27 |
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis |
Md Anwarul Azim Majumder, Mohammed S. Razzaque |
| 78 |
[GO] |
2022―Apr―26 |
Correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination” |
Rujittika Mungmungpuntipantip, Viroj Wiwanitkit |
| 79 |
[GO] |
2022―Apr―15 |
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction |
Claudio Marabotti |
| 80 |
[GO] |
2022―Apr―07 |
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the Delta variant in Italy, 19 July to 12 December 2021 |
Massimo Fabiani, Maria Puopolo, Antonietta Filia, Chiara Sacco, Alberto Mateo-Urdiales, Stefania Spila Alegiani, Martina Del Manso, Fortunato D’Ancona, Fenicia Vescio, Marco Bressi, Daniele Petrone, Matteo Spuri, Maria Cristina Rota, Marco Massari, Roberto Da Cas, Cristina Morciano, Paola Stefanelli, Antonino Bella, Marco Tallon, Valeria Proietti, Andrea Siddu, Serena Battilomo, Anna Teresa Palamara, Patrizia Popoli, Silvio Brusaferro, Giovanni Rezza, Flavia Riccardo, Francesca Menniti Ippolito, Patrizio Pezzotti |
| 81 |
[GO] |
2022―Apr―04 |
Influence of social media on the public perspectives of the safety of COVID-19 vaccines |
Sai Krishna Gudi, Sophia M. George, Jimmy Jose |
| 82 |
[GO] |
2022―Mar―22 |
Current status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women |
Swagat Kumar Das, Manish Paul, Bikash Chandra Behera, Hrudayanath Thatoi |
| 83 |
[GO] |
2022―Mar―14 |
Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis |
Maryam Nikpour, Mahdi Sepidarkish, Shabnam Omidvar, Mojgan Firouzbakht |
| 84 |
[GO] |
2022―Feb―22 |
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis |
Michele Gringeri, Vera Battini, Gianluca Cammarata, Giulia Mosini, Greta Guarnieri, Chiara Leoni, Marco Pozzi, Sonia Radice, Emilio Clementi, Carla Carnovale |
| 85 |
[GO] |
2022―Feb―14 |
Clinical development and approval of COVID-19 vaccines |
Ulrich Kalinke, Dan H. Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather, Pieter Neels |
| 86 |
[GO] |
2022―Feb―03 |
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis |
Chia-Wei Chu, Zhu Liduzi Jiesisibieke, Yu-Pei Yang, Pao-Chu Wu, Hong-Liang Lin, Tao-Hsin Tung |
| 87 |
[GO] |
2022―Feb―03 |
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies |
Manuela Di Fusco, Jay Lin, Shailja Vaghela, Melissa Lingohr-Smith, Jennifer L. Nguyen, Thomas Scassellati Sforzolini, Jennifer Judy, Alejandro Cane, Mary M. Moran |
| 88 |
[GO] |
2022―Jan―25 |
Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis |
Ataru Igarashi, Yosuke Nakano, Mariko Yoneyama-Hirozane |
| 89 |
[GO] |
2022―Jan―20 |
Immunization in pregnancy to protect pregnant people and their newborns against COVID-19 |
Mahin Delara, Manish Sadarangani |
| 90 |
[GO] |
2022―Jan―06 |
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa |
Charles S Wiysonge, Samuel M Alobwede, Patrick de Marie C Katoto, Elvis B Kidzeru, Evelyn N Lumngwena, Sara Cooper, Rene Goliath, Amanda Jackson, Muki S Shey |
| 91 |
[GO] |
2022―Jan―04 |
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital |
Marta (M) Valera-Rubio, María Isabel (MI) Sierra-Torres, Raquel (R) Castillejo García, Jaime (J) Cordero-Ramos, María Reyes (MR) López-Márquez, Óscar (O) Cruz-Salgado, Miguel Ángel (MA) Calleja-Hernández |
| 92 |
[GO] |
2022―Jan―02 |
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign |
Jiahao Wang, He Zhu, Xiaozhen Lai, Haijun Zhang, Yingzhe Huang, Huangyufei Feng, Yun Lyu, Rize Jing, Jia Guo, Hai Fang |
| 93 |
[GO] |
2021―Dec―30 |
Looking to the future: is a universal coronavirus vaccine feasible? |
Vipin M. Vashishtha, Puneet Kumar |
| 94 |
[GO] |
2021―Dec―28 |
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China |
Peng Zhang, Kaisheng Fan, Hanwen Guan, Qiao Zhang, Xuejing Bi, Yangmu Huang, Libo Liang, Abdul Rahman Khoso, Mingli Jiao, Zheng Kang, Yanhua Hao, Qunhong Wu |
| 95 |
[GO] |
2021―Dec―27 |
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines |
Pedro L. Moro, Michael M. McNeil |
| 96 |
[GO] |
2021―Dec―24 |
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy |
Aida Bianco, Giorgia Della Polla, Silvia Angelillo, Concetta P Pelullo, Francesca Licata, Italo F. Angelillo |
| 97 |
[GO] |
2021―Dec―23 |
The road to achieving herd immunity: factors associated with Singapore residents’ uptake and hesitancy of the COVID-19 vaccination |
Li Feng Tan, Chan Yiong Huak, Isabel Siow, Angel Justina Tan, Preetha Menon Venugopalan, Arthi Premkumar, Santhosh Kumar Seetharaman, Tan Yong Qiang Benjamin |
| 98 |
[GO] |
2021―Dec―23 |
The race for a COVID-19 vaccine: where are we up to? |
Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan, Vasso Apostolopoulos |
| 99 |
[GO] |
2021―Dec―16 |
Predicting the risk of severe COVID-19 outcomes in primary care: development and validation of a vulnerability index for equitable allocation of effective vaccines |
Francesco Lapi, Alexander Domnich, Ettore Marconi, Alessandro Rossi, Ignazio Grattagliano, Erik Lagolio, Gerardo Medea, Aurelio Sessa, Iacopo Cricelli, Giancarlo Icardi, Claudio Cricelli |
| 100 |
[GO] |
2021―Dec―13 |
COVID-19 vaccine trials and sex-disaggregated data |
Musaddique Hussain, Mehwish Fatima, Shahid Muhammad Iqbal, Muhammad Asif, Malik Saad Ullah, Imran Mukhtar, Imran Ahmad Khan, Sajida Parveen, Tahreem Fayaz, Najia Shabbir, Aisha Kanwal, Saira Shaukat, Mobeen Fatima, Nadia Ikram, Abdul Majeed, Farzana Parveen, Muhammad Tariq, Qasim Barkat, Ximei Wu |
| 101 |
[GO] |
2021―Dec―13 |
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China |
Tao-Hsin Tung, Xiao-Qing Lin, Yan Chen, Mei-Xian Zhang, Jian-Sheng Zhu |
| 102 |
[GO] |
2021―Dec―08 |
Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic |
Emrah Altindis |
| 103 |
[GO] |
2021―Dec―08 |
Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China |
Chengwen Luo, Mei-Xian Zhang, Gui-Feng Shi, Hai-Xiao Chen, Tao-Hsin Tung |
| 104 |
[GO] |
2021―Dec―02 |
Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent? |
Jessica Kaufman, Jane Tuckerman, Margie Danchin |
| 105 |
[GO] |
2021―Nov―30 |
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis |
Chia-Wei Fan, Jung-Sheng Chen, Frimpong-Manso Addo, Emma Sethina Adjaottor, Gifty Boakye Amankwaah, Cheng-Fang Yen, Daniel Kwasi Ahorsu, Chung-Ying Lin |
| 106 |
[GO] |
2021―Nov―29 |
Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital |
Ferhat Arslan, Burcu Isık Goren, Begumhan Baysal, Haluk Vahaboğlu |
| 107 |
[GO] |
2021―Nov―20 |
What are the challenges faced by COVID-19 vaccines? |
Mohnad Abdalla, Amr Ahmed El-Arabey, Xinyi Jiang |
| 108 |
[GO] |
2021―Nov―17 |
Eyedrop vaccination: an immunization route with promises for effective responses to pandemics |
Jihei Sara Lee, Sangchul Yoon, Soo Jung Han, Eun-Do Kim, Jiyeon Kim, Hae-Sol Shin, Kyoung Yul Seo |
| 109 |
[GO] |
2021―Nov―11 |
COVID-19 vaccine equity: a health systems and policy perspective |
Remco van de Pas, Marc-Alain Widdowson, Raffaella Ravinetto, Prashanth N Srinivas, Theresa J. Ochoa, Thierno Oumar Fofana, Wim Van Damme |
| 110 |
[GO] |
2021―Oct―28 |
COVID-19 Vaccine Mandate for Healthcare Workers in the United States: A Social Justice Policy |
Kobina Hagan, Rebecca Forman, Elias Mossialos, Paul Ndebele, Adnan A. Hyder, Khurram Nasir |
| 111 |
[GO] |
2021―Oct―26 |
Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants |
Bhaswati Chatterjee, Suman S. Thakur |
| 112 |
[GO] |
2021―Oct―13 |
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways |
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin |
| 113 |
[GO] |
2021―Oct―07 |
Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil |
Victor Santana Santos, Sarah Cristina Fontes Vieira, Ikaro Daniel de Carvalho Barreto, Vanessa Tavares de Gois-Santos, Ariel Oliveira Celestino, Carla Domingues, Luis Eduardo Cuevas, Ricardo Queiroz Gurgel |
| 114 |
[GO] |
2021―Oct―01 |
COVID-19 vaccination in pregnant and lactating women: a systematic review |
Raffaele Falsaperla, Guido Leone, Maria Familiari, Martino Ruggieri |
| 115 |
[GO] |
2021―Sep―28 |
DNA vaccines for SARS-CoV-2: towards third generation vaccination era |
Vivek P Chavda, Radhika Pandya, Vasso Apostolopoulos |
| 116 |
[GO] |
2021―Sep―10 |
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh |
Raeed Jamiruddin, Ahsanul Haq, Mohib Ullah Khondoker, Tamanna Ali, Firoz Ahmed, Shahad Saif Khandker, Irfan Jawad, Rubel Hossain, Sohel Ahmed, Sabita Rezwana Rahman, Mamun Mustafi, Taku Kaitsuka, Masayasu Mie, Kazuhito Tomizawa, Eiry Kobatake, Mainul Haque, Nihad Adnan |
| 117 |
[GO] |
2021―Aug―20 |
To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination |
Nan-Chang Chiu, Hsin Chi, Yu-Kang Tu, Ya-Ning Huang, Yu-Lin Tai, Shun-Long Weng, Lung Chang, Daniel Tsung-Ning Huang, Fu-Yuan Huang, Chien-Yu Lin |
| 118 |
[GO] |
2021―Aug―20 |
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey |
Weifeng Huang, Xiaoping Shao, Abram L. Wagner, Yan Chen, Baichu Guan, Matthew L. Boulton, Bingzhe Li, Linjie Hu, Yihan Lu |
| 119 |
[GO] |
2021―Aug―18 |
The associations of geographic location and perceived risk of infection with the intentions to get vaccinated against COVID-19 in China |
Rize Jing, Li Li, Jia Guo, Yifan Song, Shufan Geng, Jiaohao Wang, Haijun Zhang, Xiaozhen Lai, Yun Lyu, Huangyufei Feng, Wenzhou Yu, He Zhu, Hai Fang |
| 120 |
[GO] |
2021―Aug―11 |
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China |
Mei-Xian Zhang, Xiao-Qing Lin, Yan Chen, Tao-Hsin Tung, Jian-Sheng Zhu |
| 121 |
[GO] |
2021―Aug―09 |
Sars-Cov-2 virus and vaccination; biological and statistical framework |
Ferhat Arslan, Handan Ankaralı |
| 122 |
[GO] |
2021―Aug―04 |
Understanding Covid-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change? |
Tehniat F Ahmed, Affan Ahmed, Sheharyar Ahmed, Haadi U Ahmed |
| 123 |
[GO] |
2021―Aug―02 |
COVID-19 vaccines approved in the European Union: current evidence and perspectives |
Stefania Bellino |
| 124 |
[GO] |
2021―Jul―27 |
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2? |
Divakar Sharma |
| 125 |
[GO] |
2021―Jul―12 |
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? |
Sara Cooper, Heidi van Rooyen, Charles Shey Wiysonge |
| 126 |
[GO] |
2021―Jul―05 |
Should we be vaccinating children against COVID-19 in high-income countries? |
Grace Li, Adam Finn, Andrew J Pollard |
| 127 |
[GO] |
2021―Jul―05 |
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh |
A.B.M. Muksudul Alam, Md. Anwarul Azim Majumder, Mainul Haque, Fatema Ashraf, Mohib Ullah Khondoker, Saidur Rahman Mashreky, Abrar Wahab, Md. Tosaddeque Hossain Siddiqui, Aftab Uddin, Taufique Joarder, S.M. Moslehuddin Ahmed, Farzana Deeba, Kamrun Nessa, Sayeeda Rahman, Iffat Jahan, Md. Zakirul Islam, Nihad Adnan, Munzur E-Murshid, Md. Shafiqul Islam, Umme Laila Urmi, Abdullah Yusuf, Nitai Chandra Sarkar, Taslim Sajjad Mallik, A.M. Selim Raza, A.K.M. Daud, Mohammed S. Razzaque |
| 128 |
[GO] |
2021―Jun―26 |
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome |
Chih-Cheng Lai, Wen-Chien Ko, Chih-Jung Chen, Po-Yen Chen, Yhu-Chering Huang, Ping-Ing Lee, Po-Ren Hsueh |
| 129 |
[GO] |
2021―Jun―26 |
COVID-19 vaccines: concerns beyond protective efficacy and safety |
Chih-Cheng Lai, I-Tzu Chen, Chien-Ming Chao, Ping-Ing Lee, Wen-Chien Ko, Po-Ren Hsueh |
| 130 |
[GO] |
2021―Jun―05 |
Reported Adverse Effects following COVID-19 Vaccination at a Tertiary Care Hospital, Focus on Cerebral Venous Sinus Thrombosis (CVST) |
Laila Carolina Abu Esba, Majed Al Jeraisy |
| 131 |
[GO] |
2021―Jun―03 |
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials |
Wenping Gong, Ashok Aspatwar, Shuyong Wang, Seppo Parkkila, Xueqiong Wu |
| 132 |
[GO] |
2021―May―20 |
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations |
Daniele Focosi, Massimo Franchini |
| 133 |
[GO] |
2021―May―14 |
The COVID-19 pandemic momentum: can it be used to support improvements in healthcare worker influenza vaccination |
Holly Seale |
| 134 |
[GO] |
2021―May―02 |
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China |
Mei-Xian Zhang, Tong-Tong Zhang, Gui-Feng Shi, Feng-Min Cheng, Yan-Ming Zheng, Tao-Hsin Tung, Hai-xiao Chen |
| 135 |
[GO] |
2021―Apr―26 |
Surveying willingness towards SARS-CoV-2 vaccination of healthcare workers in Italy |
Gabriella Di Giuseppe, Concetta P Pelullo, Giorgia Della Polla, Maria V Montemurro, Francesco Napolitano, Maria Pavia, Italo F. Angelillo |
| 136 |
[GO] |
2021―Apr―26 |
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines? |
Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos |
| 137 |
[GO] |
2021―Apr―16 |
Progress in research on the S protein as the target of COVID-19 vaccines |
Mohnad Abdalla, Amr Ahmed El-Arabey, Xinyi Jiang |
| 138 |
[GO] |
2021―Apr―16 |
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies |
Lianlian Bian, Fan Gao, Jialu Zhang, Qian He, Qunying Mao, Miao Xu, Zhenglun Liang |
| 139 |
[GO] |
2021―Mar―31 |
Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases? |
Yan Shi, Minna Guo, Wenjing Yang, Shijiang Liu, Bin Zhu, Ling Yang, Chun Yang, Cunming Liu |
| 140 |
[GO] |
2021―Mar―22 |
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. |
Rick Heida, Wouter LJ Hinrichs, Henderik W Frijlink |
| 141 |
[GO] |
2021―Mar―20 |
Letter to the editor to: Verger P and Dubé E. Restoring confidence in vaccines in the COVID-19 era, Expert Review of Vaccines, 2020; 19(11):991-3 |
Iman Ridda, Richard Chamberlain, Rita Haber, Harunor Rashid |
| 142 |
[GO] |
2021―Feb―18 |
COVID-19 and the rise of anti-science |
Peter Hotez |
| 143 |
[GO] |
2021―Feb―17 |
Improving pandemic preparedness through better, faster influenza vaccines |
Matthew Newland, David Durham, Jason Asher, John J. Treanor, Jonathan Seals, Ruben O. Donis, Robert Johnson |
| 144 |
[GO] |
2021―Feb―08 |
Latin American forum on immunization services during the COVID-19 pandemic |
María L. Ávila-Agüero, Sebastián Ospina-Henao, María C. Pirez, Ángela Gentile, Soraya Araya, José Brea, Lourdes Mendoza, Luiza H. Falleiros-Arlant |
| 145 |
[GO] |
2021―Jan―15 |
Immunoinformatics-guided Designing and In Silico Analysis of Epitope-based Polyvalent Vaccines against Multiple Strains of Human Coronavirus (HCoVs) |
Bishajit Sarkar, Asad Ullah, Yusha Araf, Nafisa Nawal Islam, Umme Salma Zohora |
| 146 |
[GO] |
2021―Jan―15 |
COVID-19 vaccine: where are we now and where should we go? |
Saman Soleimanpour, Atieh Yaghoubi |
| 147 |
[GO] |
2020―Nov―30 |
Why METH users are at high risk of fatality due to COVID-19 infection? |
Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos |
| 148 |
[GO] |
2020―Nov―28 |
Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery |
Guo Dai, Mei Huang, To Sing Fung, Ding Xiang Liu |
| 149 |
[GO] |
2020―Oct―27 |
COVID-19 in healthcare workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines |
Rémi Labetoulle, Maëlle Detoc, Julie Gagnaire, Philippe Berthelot, Carole Pelissier, Luc Fontana, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon |
| 150 |
[GO] |
2020―Sep―23 |
“Mindful” development of rapid, safe and effective COVID-19 vaccines |
Leonard Moise, Ted M. Ross, Daniel F. Hoft, William D. Martin, Anne S. De Groot |
| 151 |
[GO] |
2020―Sep―18 |
How can a global pandemic affect vaccine hesitancy? |
Eve Dubé, Noni E MacDonald |
| 152 |
[GO] |
2020―Sep―17 |
Restoring confidence in vaccines in the COVID-19 era |
Pierre Verger, Eve Dubé |
| 153 |
[GO] |
2020―Sep―17 |
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations |
Janet Sultana, Giampiero Mazzaglia, Nicoletta Luxi, Antonino Cancellieri, Annalisa Capuano, Carmen Ferrajolo, Chiara de Waure, Guido Ferlazzo, Gianluca Trifirò |
| 154 |
[GO] |
2020―Sep―01 |
Designing an Efficient Multi-Epitope Vaccine Displaying Interactions with Diverse HLA Molecules for an Efficient Humoral and Cellular Immune Response to prevent COVID-19 infection. |
Mrutyunjay Suar, Soumya Mahapatra, Susrita Sahoo, Budheswar Dehury, Vishakha Raina, Shubhransu Patro, Namrata Misra |
| 155 |
[GO] |
2020―Aug―26 |
An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies |
Naru Zhang, Jian Shang, Chaoqun Li, Kehui Zhou, Lanying Du |
| 156 |
[GO] |
2020―Aug―25 |
Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns |
Raphaël M. Zellweger, T. Anh Wartel, Florian Marks, Manki Song, Jerome H. Kim |
| 157 |
[GO] |
2020―Aug―20 |
Exploring the SARS-CoV-2 structural proteins for Multi-Epitope vaccine development: an in-silico approach |
Amit Kumar, Prateek Kumar, Kumar Udit Saumya, Shivani K. Kapuganti, Taniya Bhardwaj, Rajanish Giri |
| 158 |
[GO] |
2020―Aug―06 |
The potential impact of COVID-19 pandemic on the immunization performance in Indonesia |
Auliya A. Suwantika, Cornelis Boersma, Maarten J. Postma |
|
